The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Moves on Peptides: What Compounding Pharmacies Need to Know When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Can BPC 157 Help with Erectile Dysfunction? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post